Merck & Co. Inc. buy SVB Leerink LLC
Start price
13.01.25
/
50%
€98.40
Target price
13.01.26
€116.64
Performance (%)
-6.00%
End price
14.01.26
€92.50
Summary
This prediction ended on 14.01.26 with a price of €92.50. With a performance of -6.00%, the BUY prediction by SVB_Leerink_LLC finished with a loss. Dividends of €0.81 are taken into consideration when calculating the performance. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 10.849% | 10.849% | 21.842% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Leerink Partners from $136.00 to $119.00. They now have an "outperform" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten